SMTL ID : 4ogi.2 (1 other biounit)

Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor BI-2536

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.73 Å

Oligo State

monomer

Ligands

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 5 residues within 4Å: Chain A: I.59, I.60, K.61, T.62, N.94 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:I.59, A:K.61, A:T.62, A:T.62, A:N.94

1 x R78: 4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide(Non-covalent)

R78.2: 11 residues within 4Å: Chain A: W.40, P.41, F.42, V.46, L.51, L.53, Y.56, C.95, Y.98, N.99, I.105 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.46, A:L.53, A:Y.56, A:Y.98, A:I.105 Hydrogen bonds: A:N.99 pi-Stacking: A:W.40

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ciceri, P. et al., Dual kinase-bromodomain inhibitors for rationally designed polypharmacology. Nat.Chem.Biol. (2014)

Release Date

2014-02-26

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Bromodomain-containing protein 4

Related Entries With Identical Sequence